Stock plunges for peanut allergy patch maker
October 23, 2017 at 11:46 AM EDT
Stock drops 50% for DBV Technologies after its Viaskin peanut allergy patch fails to clear clinical trials, providing a boost for competitor Aimmune.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.